Cancer Diagnosis and Prognosis After Guillain–Barré Syndrome: A Population-Based Cohort Study

References

• Dimachkie MM, Barohn RJ. Guillain-Barré syndrome and variants. Neurol Clin. 2013;31(2):491–510. doi:10.1016/j.ncl.2013.01.005
   PubMed Web of Science ®Google Scholar
• McGrogan A, Madle GC, Seaman HE, de Vries CS. The epidemiology of Guillain-Barré syndrome worldwide. A systematic literature review. Neuroepidemiology. 2009;32(2):150–163. doi:10.1159/000184748
   PubMed Web of Science ®Google Scholar
• Levison LS, Thomsen RW, Sindrup SH, Andersen H. Association between incident cancer and Guillain-Barré syndrome development: a nationwide case-control study. Neurology. 2022;2:10.1212.
   Google Scholar
• Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med. 2003;349(16):1543–1554. doi:10.1056/NEJMra023009
   PubMed Web of Science ®Google Scholar
• Naveed S, Okoli K, Hollingsworth J, Kasmani R. Guillain-Barré syndrome as a paraneoplastic manifestation of small-cell carcinoma of lung. South Med J. 2010;103(2):156–158. doi:10.1097/SMJ.0b013e3181bfd2c0
   Web of Science ®Google Scholar
• Eimil M, Benito-León J. Guillain-Barré-like syndrome heralding small-cell lung cancer. Eur J Neurol. 2007;14(11):e15–e16. doi:10.1111/j.1468-1331.2007.01957.x
   Google Scholar
• Jung I, Gurzu S, Balasa R, et al. A coin-like peripheral small cell lung carcinoma associated with acute paraneoplastic axonal Guillain-Barre-like syndrome. Medicine. 2015;94(22):e910. doi:10.1097/MD.0000000000000910
   Web of Science ®Google Scholar
• Wu D, Liu A, Baldinger E, Frontera AT. A case of paraneoplastic Guillain-Barré syndrome associated with squamous cell carcinoma of the lung. Cureus. 2018;10(8):e3202. doi:10.7759/cureus.3202
   Web of Science ®Google Scholar
• Nokura K, Nagamatsu M, Inagaki T, et al. Acute motor and sensory neuronopathy associated with small-cell lung cancer: a clinicopathological study. Neuropathology. 2006;26(4):329–337. doi:10.1111/j.1440-1789.2006.00698.x
   Web of Science ®Google Scholar
• Lagrange E, Veran O, Besson G. Pure motor relapsing Guillain-Barré syndrome associated with anti-GM1 antibodies revealing urinary bladder cancer. Eur J Neurol. 2007;14(12):e7. doi:10.1111/j.1468-1331.2007.01990.x
   Web of Science ®Google Scholar
• Kim MH, Hwang MS, Park YK, et al. Paraneoplastic Guillain-Barré syndrome in small cell lung cancer. Case Rep Oncol. 2015;8(2):295–300. doi:10.1159/000437295
   PubMedGoogle Scholar
• Ferrufino E, Camarasa A, Chiner E. Guillain-Barre syndrome as an initial manifestation of small cell lung carcinoma. Arch Bronconeumol. 2011;47(2):107–108. doi:10.1016/j.arbres.2010.08.006
   Web of Science ®Google Scholar
• Vallat JM, De Mascarel HA, Bordessoule D, et al. Non-Hodgkin malignant lymphomas and peripheral neuropathies–13 cases. Brain. 1995;118(Pt 5):1233–1245. doi:10.1093/brain/118.5.1233
   Web of Science ®Google Scholar
• Rodrigues A, Monteiro A, Viana J, Macedo A, Graca F, Sena A. Acute non-lymphoblast leukaemia presenting as a Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry. 1993;56(8):936–937. doi:10.1136/jnnp.56.8.936-A
   Web of Science ®Google Scholar
• Christodoulou C, Anastasopoulos D, Visvikis A, et al. Guillain-Barré syndrome in a patient with metastatic colon cancer receiving oxaliplatin-based chemotherapy. Anticancer Drugs. 2004;15(10):997–999. doi:10.1097/00001813-200411000-00010
   PubMed Web of Science ®Google Scholar
• Zilli T, Allal AS. Guillain-Barré syndrome as an atypical manifestation of an esophageal carcinoma. Neurol Sci. 2011;32(1):151–153. doi:10.1007/s10072-010-0363-9
   Web of Science ®Google Scholar
• Lisak RP, Mitchell M, Zweiman B, Orrechio E, Asbury AK. Guillain-Barré syndrome and Hodgkin’s disease: three cases with immunological studies. Ann Neurol. 1977;1(1):72–78. doi:10.1002/ana.410010107
   Web of Science ®Google Scholar
• Re D, Schwenk A, Hegener P, Bamborschke S, Diehl V, Tesch H. Guillain-Barré syndrome in a patient with non-Hodgkin’s lymphoma. Ann Oncol. 2000;11(2):217–220. doi:10.1023/A:1008389607293
   PubMed Web of Science ®Google Scholar
• Vigliani MC, Magistrello M, Polo P, Mutani R, Chiò A. Risk of cancer in patients with Guillain-Barré syndrome (GBS). A population-based study. J Neurol. 2004;251(3):321–326. doi:10.1007/s00415-004-0317-3
   PubMed Web of Science ®Google Scholar
• Hiew FL, Rajabally YA. Malignancy in Guillain-Barré syndrome: a twelve-year single-center study. J Neurol Sci. 2017;375:275–278. doi:10.1016/j.jns.2017.02.024
   Web of Science ®Google Scholar
• Maddison P, Lang B, Thomsen S, et al. Prospective study of cancer survival in patients with HuD-antibody-associated paraneoplastic neurological disorders. J Neurol Neurosurg Psychiatry. 2021;92(12):1350–1351. doi:10.1136/jnnp-2021-326067
   Web of Science ®Google Scholar
• Shah S, Flanagan EP, Paul P, et al. Population-based epidemiology study of paraneoplastic neurologic syndromes. Neurol Neuroimmunol Neuroinflamm. 2022;9(2). doi:10.1212/NXI.0000000000001124
   Web of Science ®Google Scholar
• Schmidt M, Schmidt SAJ, Adelborg K, et al. The Danish health care system and epidemiological research: from health care contacts to database records. Clin Epidemiol. 2019;11:563–591. doi:10.2147/CLEP.S179083
   PubMed Web of Science ®Google Scholar
• Schmidt M, Pedersen L, Sørensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol. 2014;29(8):541–549. doi:10.1007/s10654-014-9930-3
   PubMed Web of Science ®Google Scholar
• Schmidt M, Schmidt SA, Sandegaard JL, Ehrenstein V, Pedersen L, Sørensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–490. doi:10.2147/CLEP.S91125
   PubMed Web of Science ®Google Scholar
• Gjerstorff ML. The Danish Cancer Registry. Scand J Public Health. 2011;39(7_suppl):42–45. doi:10.1177/1403494810393562
   PubMed Web of Science ®Google Scholar
• Levison LS, Thomsen RW, Christensen DH, Mellemkjær T, Sindrup SH, Andersen H. Guillain-Barré syndrome in Denmark: validation of diagnostic codes and a population-based nationwide study of the incidence in a 30-year period. Clin Epidemiol. 2019;11:275–283. doi:10.2147/CLEP.S199839
   Web of Science ®Google Scholar
• Danish Health Data Authority, Nye Kræfttilfælde i Danmark; 2017. Available from: file:///C:/Users/AU125348/Downloads/Kraefttilfaelde%202017.pdf. Accessed July 7, 2022.
   Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi:10.1016/0021-9681(87)90171-8
   PubMedGoogle Scholar
• Kanaji N, Watanabe N, Kita N, et al. Paraneoplastic syndromes associated with lung cancer. World J Clin Oncol. 2014;5(3):197–223. doi:10.5306/wjco.v5.i3.197
   PubMedGoogle Scholar
• Giometto B, Grisold W, Vitaliani R, Graus F, Honnorat J, Bertolini G. Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers. Arch Neurol. 2010;67(3):330–335. doi:10.1001/archneurol.2009.341
   PubMedGoogle Scholar